NKore Biotherapeutics, LLC — Form D
NKore Biotherapeutics, LLC of GERMANTOWN, TN, a company, filed a Form D exempt-offering notice with the SEC on 2023-04-13. The offering totals $3.0M, of which $250K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-04-13
- Form: D
- Accession: 0001973285-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $250K
- Remaining: $2.8M
- Minimum investment: $25K
- Investors: 2
- Date of first sale: 2023-03-24
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-478808
Issuer
- Name: NKore Biotherapeutics, LLC
- CIK: 0001973285
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 2309 DUNTREATH RD, GERMANTOWN, TN, 38139
- Phone: 615-618-9548
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Timothy Brahm | Director | Germantown, TN |
| R Gregory Brophy | Director | Nashville, TN |
| Tracy Ryan | Director | Sherman Oaks, CA |
| Diederik van der Reijt | Director | Lisbon, S1 |
| R Gregory Brophy | Executive Officer | Nashville, TN |
| Tracy Ryan | Executive Officer | Sherman Oaks, CA |
More